- CMS Informational bulletin.(Available at:)https://www.medicaid.gov/federal-policy-guidance/downloads/cib011717.pdfDate accessed: November 5, 2018
- Improving patient and health system outcomes through advanced pharmacy practice. A report to the U.S. Surgeon General.Office of the Chief Pharmacist, U.S. Public Health Service, Washington, DC2011
- Select features of state pharmacist collaborative practice laws.(Available at:)https://www.cdc.gov/dhdsp/pubs/docs/pharmacist_state_law.pdfDate accessed: November 5, 2018
- Getting to Zero: New HIV Diagnoses in San Francisco: What will it take? Presented at the 25th Conference on Retroviruses and Opportunistic Infections. Abstract 87. Boston, MA: March 4-7.2018
- San Francisco, Department of Public Health.(Available at:)https://www.sfdph.org/dph/files/reports/RptsHIVAIDS/AnnualReport2017-Green-20180904-Web.pdfDate accessed: January 5, 2019
- Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project.J Am Pharm Assoc. 2017; 57: 510-515.e2
- US community pharmacies as CLIA-waived facilities: prevalence, dispersion, and impact on patient access to testing.Res Social Adm Pharm. 2016; 12: 614-621
- University of Washington National STD Curriculum.(Available at:)https://www.std.uw.edu/Date accessed: January 5, 2019
- Feasability of a pharmacist run HIV PrEP clinic in a community pharmacy setting. Presented at the 23rd Conference on Retroviruses and Opportunistic Infections. Abstract 961. Seattle, WA: February 13-16.2017
- DHHS Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV.(Available at:)https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-arv/0Date accessed: November 5, 2018
- Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy.AIDS Patient Care STDS. 2012; 26: 526-531
- Improved antiretroviral refill adherence in HIV-focused community pharmacies.J Am Pharm Assoc. 2012; 52: e67-e73
- The “no wrong door approach” to HIV testing: Results from a statewide retail pharmacy-based HIV testing program in Virginia, 2014-206.Public Health Rep. 2018; 133: 34S-42S
- HIV pre-exposure prophylaxis: exploring the potential for expanding the role of pharmacists in public health.J Am Pharm Assoc. 2018; 58: 412-420.e
- Walgreens healthcare clinics to offer testing services for sexually transmitted infections, including HIV, hepatitis and others.(Available at:)http://www.businesswire.com/news/home/20170418005305/en/Date accessed: January 30, 2019
- Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care.Sex Health. 2018; 15: 556-561
- HIV Surveillance Report, 2017; vol. 29.(Available at:)http://www.cdc.gov/hiv/library/reports/hiv-surveillance.htmlDate accessed: December 17, 2018
- HIV in the United States and Dependent Areas.(Available at:)https://www.cdc.gov/hiv/statistics/overview/ataglance.htmlDate accessed: January 5, 2019
- US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: a clinical practice guideline.(Available at:)https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdfDate accessed: December 17, 2018
- Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.N Engl J Med. 2010; 363: 2587-2599
Highleyman L. PrEP use is rising fast in US, but large racial disparities remain. Available at: http://www.aidsmap.com/news/jun-2016/prep-use-rising-fast-us-large-racial-disparities-remain. Accessed July 26, 2019.
- The availability of pharmacies in the United States: 2007-2015.PLoS One. 2017; 12: e0183172
- First ever data on PrEP users across the US.(Available at:)https://aidsvu.org/prep/Date accessed: January 5, 2019
- HIV prevention pill not reaching most Americans who could benefit–especially people of color.(Available at:)http://www.cdc.gov/nchhstp/newsroom/2018/croi-2018-PrEP-press-release.htmlDate accessed: June 10, 2019
Disclosure: The authors declare no conflicts of interest or financial interests in any product or service mentioned in this article.
Note that this paper does not constitute legal advice, and counsel should be consulted before implementing a program of this nature.
Funding: The program received funding from the City and County of San Francisco Getting To Zero (CCSF-GTZ); CMS# 7407 and Project Pride, Centers for Disease Control and Prevention (CDC); Grant # NU62PS0005027-02-00.